Eva Font

Eva Font is Start-up and Regulatory Director at Pivotal.

Articles by Eva Font

Clinical practice across the EU and the UK is broadly comparable, supported by shared scientific guidance and similar treatment frameworks. Credit: Stock.Adobe.com/donfiore.

One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform

June 15th 2026

How sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.

Eva Font

Articles by Eva Font

One Strategy, Two Jurisdictions: Unlocking Efficiency Across EU CTR and UK Regulatory Reform

Latest Updated Articles

Trending on Applied Clinical Trials Online

FDA Seeks Public Input on Early-Phase Clinical Trial Design for Ibogaine

FDA Releases Transparency Roadmap Outlining Disclosure Priorities Across Drug Development and Regulatory Review

Mixed Outsourcing Models Are Spreading. Is Sponsor Oversight Keeping Up?

Beyond the Molecule: Why Radiopharmaceutical Trials Require a New Operating Model

Operation TrialBlazer Leveraging New and Anticipated US Policy Changes in Early Development